Malignant neoplasm of breast
|
0.620 |
AlteredExpression
|
disease |
BEFREE |
The top 370 probe sets that were differentially expressed between BCBM and both BC and prBT were in the majority comparably overexpressed in BCBM and included, e.g. the coding genes BCL3, BNIP3, BNIP3P1, BRIP1, CASP14, CDC25A, DMBT1, IDH2, E2F1, MYCN, RAD51, RAD54L, and VDR.
|
29287594 |
2017 |
Malignant neoplasm of breast
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
However, RAD54L rs1710286 and RPA1 rs11078676 were not observed to be associated with either the risk or survival of BC.
|
28940489 |
2017 |
Malignant neoplasm of breast
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Malignant neoplasm of breast
|
0.620 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Malignant neoplasm of breast
|
0.620 |
Biomarker
|
disease |
CTD_human |
|
|
|
Lymphoma, Non-Hodgkin
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Lymphoma, Non-Hodgkin
|
0.600 |
CausalMutation
|
disease |
CGI |
|
|
|
Lymphoma, Non-Hodgkin
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Adenocarcinoma of colon
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Adenocarcinoma of colon
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Adenocarcinoma of colon
|
0.600 |
CausalMutation
|
disease |
CGI |
|
|
|
Lymphoma, Non-Hodgkin, Familial
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Lymphoma, Non-Hodgkin, Familial
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Lymphoma, Non-Hodgkin, Familial
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Breast Carcinoma
|
0.420 |
GeneticVariation
|
disease |
BEFREE |
However, RAD54L rs1710286 and RPA1 rs11078676 were not observed to be associated with either the risk or survival of BC.
|
28940489 |
2017 |
Breast Carcinoma
|
0.420 |
AlteredExpression
|
disease |
BEFREE |
The top 370 probe sets that were differentially expressed between BCBM and both BC and prBT were in the majority comparably overexpressed in BCBM and included, e.g. the coding genes BCL3, BNIP3, BNIP3P1, BRIP1, CASP14, CDC25A, DMBT1, IDH2, E2F1, MYCN, RAD51, RAD54L, and VDR.
|
29287594 |
2017 |
Breast Carcinoma
|
0.420 |
Biomarker
|
disease |
HPO |
|
|
|
Breast Carcinoma
|
0.420 |
Biomarker
|
disease |
CTD_human |
|
|
|
Mammary Neoplasms
|
0.310 |
Biomarker
|
group |
BEFREE |
We have examined the hRAD54 gene in several breast tumors and breast tumor cell lines and, although the gene region appears to be deleted in several tumors, at present we have found no coding sequence mutations.
|
9192813 |
1997 |
Mammary Neoplasms
|
0.310 |
Biomarker
|
group |
CTD_human |
|
|
|
Liver carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
|
28284560 |
2017 |
Reticulosarcoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Lymphoma, Mixed-Cell
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Lymphoma, Undifferentiated
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
High Grade Lymphoma (neoplasm)
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|